117 related articles for article (PubMed ID: 3515552)
1. Leg ulcer infection with an erythromycin-resistant Streptococcus pyogenes.
Hardie R; Hardie RA
Scott Med J; 1986 Jan; 31(1):39. PubMed ID: 3515552
[No Abstract] [Full Text] [Related]
2. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona].
Viñado B; Domínguez J; Rodrigo C; Matas L
Med Clin (Barc); 1999 Apr; 112(14):556. PubMed ID: 10363246
[No Abstract] [Full Text] [Related]
3. Chemotherapy of streptococcal infections: implications of antimicrobial drug resistance in Streptococcus pyogenes.
Hansman D
Med J Aust; 1989 Jun; 150(11):611-2. PubMed ID: 2657346
[No Abstract] [Full Text] [Related]
4. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic implications of erythromycin resistance in group A streptococci.
Coonan K; Kaplan EL
Pediatr Infect Dis J; 1993 Mar; 12(3):261-2. PubMed ID: 8451111
[No Abstract] [Full Text] [Related]
6. Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
Borzani M; Varotto F; Garlaschi L; Conio F; Dell'Olio M; Careddu P
J Chemother; 1989 Jul; 1(4 Suppl):392-4. PubMed ID: 16312455
[No Abstract] [Full Text] [Related]
7. Streptococcus pyogenes: resistant, tolerant, neither or both?
Mortensen JE; McDowell T
Adv Exp Med Biol; 1995; 390():109-17. PubMed ID: 8718606
[No Abstract] [Full Text] [Related]
8. Erythromycin resistance in Finland declines after reduction in macrolide use.
Am J Health Syst Pharm; 1997 Nov; 54(21):2436-7. PubMed ID: 9359947
[No Abstract] [Full Text] [Related]
9. [Resistance to macrolides in Streptococcus pyogenes].
Bellido JL; García-Sáenz JA; Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Rev Esp Quimioter; 1998 Sep; 11(3):196-204. PubMed ID: 9795305
[No Abstract] [Full Text] [Related]
10. Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.
Dixon JM; Lipinski AE
J Infect Dis; 1974 Oct; 130(4):351-6. PubMed ID: 4613758
[No Abstract] [Full Text] [Related]
11. [Streptococcus pyogenes and resistance to macrolides: experience at Monza].
Minerva Pediatr; 1998; 50(1-2):XII-XIII. PubMed ID: 9658791
[No Abstract] [Full Text] [Related]
12. Erythromycin-resistant Streptococcus pyogenes in Argentina.
Lopardo HA; Hernandez C; Vidal P; Vazquez M; Rosaenz L; Rubinstein G; Smayevsky J; Tokumoto M; Fernandez Lausi A; Daher O; Kaufman S; Soriano SV; Brasili S; Bottiglieri M; Carranza MC
Medicina (B Aires); 2004; 64(2):143-5. PubMed ID: 15628302
[TBL] [Abstract][Full Text] [Related]
13. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
14. Erythromycin resistant Streptococcus pyogenes in Cambridge.
Walker M; Whetstone RJ; Whipp J
J Infect; 1984 Jan; 8(1):88-9. PubMed ID: 6366072
[No Abstract] [Full Text] [Related]
15. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.
Sanders E; Foster MT; Scott D
N Engl J Med; 1968 Mar; 278(10):538-40. PubMed ID: 4966066
[No Abstract] [Full Text] [Related]
16. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
Sakran W; Raz R; Colodner R; Keness Y
Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
[TBL] [Abstract][Full Text] [Related]
17. Macrolide-resistant group a streptococcus--now in the United States.
Huovinen P
N Engl J Med; 2002 Apr; 346(16):1243-5. PubMed ID: 11961156
[No Abstract] [Full Text] [Related]
18. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
Gagliotti C; Nobilio L; Milandri M; Moro ML;
Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
[TBL] [Abstract][Full Text] [Related]
19. Increase in frequency of serious group A streptococcal infections.
Rudensky B; Isaacson M; Beck A; Greenfield J
Isr J Med Sci; 1992 Oct; 28(10):752-3. PubMed ID: 1399515
[No Abstract] [Full Text] [Related]
20. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
